Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
All Resources Treatments A-Z Personal Assistant Help Center Crisis
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

AML - Any experience with Azacitidine + Ivosidenib , with Venetoclax

A MyLeukemiaTeam Member asked a question 💭
Suwanee, GA

Look like Ivosidenib having more promising results. Any has gone this route ?

https://www.patientpower.info/acute-myeloid-leu...

https://www.youtube.com/results?search_query=Iv...+

August 7, 2023 (edited)
 · 
Be the first to react
A MyLeukemiaTeam Member

My husband was on all three thru clinical at MD Anderson. In remission with great quality of life but recently relapsed so on to the next trial.

August 12, 2023
A MyLeukemiaTeam Member

I received Vidazza and Venetoclax along with Tibsovo for AML with I DH mutation. This treatment went on for 6 rounds and am now on just the Tibsovo, and remain in remission. Doing well now but still have fatigue and shortness of breath. I feel blessed!

July 25, 2025
MyLeukemiaTeam

Based on the knowledge base:

- Azacitidine (Onureg, Vidaza): This is a chemotherapy drug used in combination with other treatments for AML
- Ivosidenib (Tibsovo): This is a targeted therapy for AML with IDH1 mutations. It works by interfering with the ability of leukemia cells to release stored energy.
- Venetoclax Show Full Answer

Based on the knowledge base:

- Azacitidine (Onureg, Vidaza): This is a chemotherapy drug used in combination with other treatments for AML.
- Ivosidenib (Tibsovo): This is a targeted therapy for AML with IDH1 mutations. It works by interfering with the ability of leukemia cells to release stored energy.
- Venetoclax (Venclexta): This is a BCL-2 inhibitor used for AML, particularly in older adults or those who cannot tolerate other treatments. It helps leukemia cells to self-destruct.

Combining these treatments can be part of a strategy to target different aspects of AML, but specific experiences and outcomes can vary. Always consult with your healthcare provider for personalized advice.

August 1, 2024
A MyLeukemiaTeam Member

Hope additional treatment will help him to get deeper remission. Wishing and praying for him.

August 12, 2023

Related Questions

View All
Palliative Care: Improving Quality of Life With Leukemia at Any Stage
How Is AML Different From CML Blast Crisis?
AML vs. CML: How Do They Differ?